Clinical trial
Multi-Center, Prospective, Consecutive, Paired Diagnosis, Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients
NCT06999122 is registered in ClinicalTrials.gov with EMVision Medical Devices Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-Center, Prospective, Consecutive, Paired Diagnosis, Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients
- Lead sponsor
- EMVision Medical Devices Ltd
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 26, 2025
- Completion date
- November 28, 2026
- Enrollment
- 300 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.